Privia Health revenue rallies 21% to $632.6 million

• Privia Health reported Q2 2026 revenue of $632.6 million, up 21.4%, while net income increased 236.7%.
• Adjusted EBITDA rose 29.1% to $37.4 million, although the shares fell 14.4% in early trading.
• The company now expects revenue at the high end and adjusted EBITDA at the middle-to-high end of its 2026 ranges.

Privia Health Group (NASDAQ:PRVA) reported Q2 2026 revenue of $632.6 million, up 21.4%, with net income reaching $9 million.

Revenue increased from $521.2 million, while attributable net income rose 236.7% from $2.7 million and diluted EPS reached $0.07.

Adjusted EBITDA increased 29.1% to $37.4 million, while adjusted net income rose 18.7% to $25.3 million.

Implemented providers increased 10.1% to 5,644, while value-based care attributed lives rose 19.2% to 1.647 million.

Privia expects revenue near the high end of $2.35–$2.45 billion.

First-half revenue increased 23.5% to $1.24 billion, while adjusted EBITDA rose 32.6% to $74.1 million.

Privia operates across 25 states and Washington, D.C., supporting more than 5,600 providers and 6.1 million patients through its healthcare platform.